Indespace Robotics Private Limited, founded in 2022 and incubated at IIT Kanpur's Startup Incubation and Innovation Centre (SIIC), is an AgTech startup tackling dystocia in India's dairy sector, focusing on incomplete cervical dilation (ICD) in cows and buffaloes. Dystocia causes prolonged labor, animal distress, reduced fetal viability, toxemia risks, and dam death. Traditional treatments like drug therapies cost 2,000 INR but have variable success, often requiring repeats in 50% of cases and taking 24.7 hours, leading to cesareans in 40.76% of instances (IVRI Bareilly data from 720 cases). Cesareans, at 6,000 INR, compromise future fertility and survival. The flagship product is a portable, battery-powered cervical softening and dilation device for non-surgical intervention. It features heat fomentation for muscle relaxation, vibratory stimulation, an inflatable sterilized silicone rubber cap with grooves for grip on slippery vulva surfaces during contractions, automatic temperature and flow control, and 20-hour operation. Made in India with a stainless-steel body, air pressure bulb, and external heating, it achieves 80% success in TD-1 tests (no fetal issues, timely use), resolving cases in 16.8 hours with 20% repeats versus drugs alone. The team includes Director Abhishek Verma (PhD in Product Design, IITK), Co-Founder Saumya Singh, Mentor Prof. J Ramkumar, Scientist Dr. Brijesh Kumar, and Director Dr. Triveni Dutt. Collaborations with IVRI for validation and IIT Kanpur for design secure a granted patent (No. 539690). Adopting a product-cum-service model, devices are priced at 30,000-40,000 INR. The market includes a TAM of 81.4 million adult female cattle and 55 million buffaloes, SAM of 68,693 veterinary clinics/hospitals, and SOM of 50,000 devices yearly (1 per small clinic, 4 per hospital for 4 daily dystocia cases). Strategies involve SOP manuals, veterinarian training, farmer education on economics, and supply chains. Government programs like NPBBDD, Livestock Health Scheme, Rashtriya Gokul Mission, and Pashu Sanjivani provide subsidies, promotion, and orders. As of September 2025, in prototype stage, the timeline targets development and testing in 2025, regulatory verification in 2026, pre-production in Q3 2026, and scaling in 2027, funded by grants and seed investment. This boosts dairy productivity, animal welfare, and livelihoods for 8.8% of India's population, including 70% women in the sector.
Show MoreYear of Establishment2022